KROMATID Blog

Experimental Design: The Foundation of Successful Cell & Gene Therapy Development Genomic Integrity Cell and Gene Therapy iPSC Therapy Starting Material Analysis In cell and gene therapy, every decision made during development has the potential to impact patient safety, product quality, regulatory success, and ultimately, commercial viability. While tremendous attention is often placed on vector design, editing efficiency, and manufacturing processes, one critical component is sometimes overlooked: thoughtful experimental design.
All HSCs Are Not Created Equal: The Importance of Testing Your Starting Material Genomic Integrity Starting Material Analysis HSC's Hematopoietic stem cells (HSCs) sit at the foundation of many cell and gene therapy programs. Whether used in autologous or allogeneic settings, ex vivo gene editing or viral transduction, HSCs are often treated as a standardized input—assumed to be equivalent as long as basic identity, viability, and purity criteria are met.
Sorry, but there are no results that match your current filters and search.
Please try a different filter combination.

Stay Updated with the Latest in Next Gen Cytogenetics.

Subscribe to our blog and get:

  • Industry Insights - The latest trends shaping the biotech world.
  • Expert Advice - Learn from proven industry leaders on regulations and compliance.
  • Exclusive Updates - Be informed on new projects, products, and services.